Mentions:
Because cytotrophoblasts do not proliferate in vitro, the MTT assay was used as a measure of cell survival. Overall, IUGR cytotrophoblasts survived less compared with normal cytotrophoblasts in response to T3 treatment (Fig. 2A; P < 0.001). Post hoc analysis revealed that this difference was significant when the cells were treated with 1 nm T3 (20% reduction; P < 0.01). There was no difference in the survival of normal and IUGR cytotrophoblasts in the absence of T3 (data not shown).

Mentions:
Because cytotrophoblasts do not proliferate in vitro, the MTT assay was used as a measure of cell survival. Overall, IUGR cytotrophoblasts survived less compared with normal cytotrophoblasts in response to T3 treatment (Fig. 2A; P < 0.001). Post hoc analysis revealed that this difference was significant when the cells were treated with 1 nm T3 (20% reduction; P < 0.01). There was no difference in the survival of normal and IUGR cytotrophoblasts in the absence of T3 (data not shown).